Optimal blood tests for development of new therapies of Alzheimer’s disease

A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting relevant treatment effects. These findings will speed up the development of new therapies that can slow down the disease progression.

Read more at: Multipark, Lund University